Anne H. Cross MD

PubMed

• Increased White Matter Aerobic Glycolysis in Multiple Sclerosis.
  Matthew R Brier, Bradley Judge, Chunwei Ying, Amber Salter, Hongyu An
  Annals of Neurology. 2025-04-01
• Claustrum Volume Is Reduced in Multiple Sclerosis and Predicts Disability.
  Nicole Shelley, Bradley Judge, Dmitriy A Yablonskiy, Robert T Naismith, Matthew R Brier
  Annals of Clinical and Translational Neurology. 2025-03-13
• Cerebrospinal fluid biomarkers as predictors of multiple sclerosis severity.
  Miguel Tolentino, Francesca Pace, Dana C Perantie, Robert Mikesell, Julia Huecker
  Multiple Sclerosis and Related Disorders. 2025-02-01

Journal Articles

• Interleukin-10 Overexpression Promotes FasL-ligand-dependent Chronic Macrophage-mediated Demyelinating Polyneuropathy  
  Dace DS, Stark JL, Kelly J, Cross AH, Apte R, PLoS ONE
• Single Scan Quantitative Gradient Recalled Echo MRI for Evaluation of Tissue Damage in Lesions and Normal Appearing Grey and White Matter in Multiple Sclerosis  
  Xiang B, Wen J, Cross AH, Yablonskiy DA., J Magn Reson Imaging, 1/29/2018
• A case report of oligodendroglioma and multiple sclerosis: Occam�s razor or Hickam�s dictum?  
  Shirani A, Wu GF, Giannini C, Cross AH., BMJ Case Rep, 1/28/2018
• Dimethyl fumarate induces changes in B- and T-lymphocyte function independent of the effects on absolute lymphocyte count  
  Longbrake EE, Cantoni C, Chahin S, Cignarella F, Cross AH, Piccio L., Mult Scler., 1/1/2018
• Intensity ratio to improve black hole assessment in multiple sclerosis  
  Adusumilli G, Trinkaus K, Sun P, Lancia S, Viox J, Wen J, Naismith RT, Cross AH., Mult Scler Rel Dis, 1/1/2018
• Vitamins and dietary supplements in multiple sclerosis A review  
  Evans E, Piccio L, Cross AH., JAMA Neurology, 1/1/2018
• Effectiveness of alternate dose fingolimod for multiple sclerosis  
  Longbrake EE, Kantor D, Pawate S, Bradshaw M, von Gerldern G, Chahin S, Cross AH, Parks B, Rice M, Khoury, Yamout B, Zeineddine M, Russell-Giller S, Caminero A, Edward..., Neurology: Clinical Practice., 1/1/2018
• Intermittent fasting confers protection in CNS autoimmunity by altering the gut microbiota  
  Cignarella F, Cantoni C, Ghezzi L, Salter A, Dorsett Y, Chen L, Weinstock GM, Fontana L, Cross AH, Zhou Y, Piccio L., Cell Metab., 1/1/2018
• Histopathological correlation of diffusion basis spectrum imaging metrics of a biopsy-proven inflammatory demyelinating brain lesion: a brief report  
  Shirani A, Sun P, Schidt RE, Trinkaus K, Naismith RT, Song SK, Cross AH., Mult Scler, 1/1/2018
• Limbic system damage in MS: MRI assessment and correlations with clinical testing  
  Wen J, Yablonskiy DA, Salter A, Cross AH., PLoS One, 1/9/2017
• Diffusion MRI quantifies early axonal loss in the presence of nerve swelling  
  Lin T-H, Chiang C-W, Perez-Torres CJ, Sun P, Wallendorf M, Schmidt RE, Cross AH, Song S-K, J Neuroinflamm, 1/1/2017
• High Risk of Post-partum Relapses in Neuromyelitis Optica Spectrum Disorder  
  Klawiter EC, Bove R, Elsone L, Alvarez E, Borisow N, Cortez M, Mateen FJ, Mealy MA, Sorum J, Mutch K, Tobyne S, Ruprecht K, Buckle G, Levy M, Wingerchuk DM, Paul F, Cr..., Neurology, 1/1/2017
• Multiple Sclerosis Disease Modifying Therapies: Effects on B-cells and Humoral Immunity  
  Longbrake EE, Cross AH, JAMA Neurol, 1/1/2016
• Dimethyl fumarate selectively reduces memory T cells in multiple sclerosis  
  Longbrake EE, Ramsbottom MJ,Cantoni C,Ghezzi L, Cross AH, Piccio L., Mult Scler., 1/1/2016
• Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: a randomized, placebo-controlled phase 2 trial  
  Voskuhl RR, Wang H, Wu TCJ, Sicotte NL, Nakamura K, Kurth F, Itoh N, Bardens J, Bernard JT, Corboy JR, Cross AH, Chib-Jalbut S, Ford CC, Frohman EM, Giesser B, Jacobs ..., Lancet Neurol., 1/1/2016
• On the relationship between cellular and hemodynamic properties of the human brain cortex throughout adult lifespan  
  Zhao Y, Wen J, Cross AH, Yablonskiy DA., Neuroimage, 1/1/2016
• A diet mimicking fasting promotes regeneration and reduces autoimmunity and multiple sclerosis symptoms  
  Choi IY, Piccio L, Childress P, Bollman B, Ghosh A, Brandhorst S, Suarez J, Michalsen A, Cross AH, Morgan TE, Wei M, Friedemann P, Bock M, Longo VD, Cell Rep, 1/1/2016
• Amelioration of EAE by a cryptic epitope of myelin oligodendrocyte glycoprotein  
  Lyons JA, Riter MM, Almatrook AM, Ramsbottom MJ, Cross AH., J Neuroimmunol., 1/1/2016
• Effect of Multiple Sclerosis Disease-Modifying Therapies on B Cells and Humoral Immunity  
  Longbrake EE, Cross AH, JAMA Neurol., 1/1/2016
• The contemporary spectrum of multiple sclerosis misdiagnosis: A multicenter study  
  Solomon AJ, Bourdette DN, Cross AH, Applebee A, Skidd PM, Howard DB, Spain RI, Cameron MH, Kim E, Mass MK, Yadav V, Whitham RH, Longbrake EE, Naismith RT, Wu GF, Parks..., Neurology, 1/1/2016
• Efficacy and Tolerability of Oral Versus Injectable Disease Modifying Therapies for Multiple Sclerosis in Clinical Practice  
  Longbrake EE, Cross AH, Salter A., Mult Scler J Exp Transl Clin., 1/1/2016
• On the Role of Physiological Fluctuations in Quantitative Gradient Echo MRI - Implications for GEPCI, QSM and SWI  
  Wen J, Cross AH, Yablonskiy D, Magn Res Med, 1/1/2015
• Differentiation and Quantification of Inflammation, Demyelination, and Axon Injury/loss in MS  
  Wang Y, Sun P, Wang Q, Trinkaus K, Naismith RT, Cross AH, Song SK, Brain, 1/1/2015
• Dimethyl Fumarate Associated Lymphopenia in Clinical Practice  
  Longbrake EE, Cross AH, Mult Scler, 1/1/2015
• TREM2 Regulates Microglial Cell Activation in Response to Demyelination in Vivo  
  Cantoni C, Bollman B, Licastro D, Xie M, Mikesell R, Schmidt R, Yuede CM, Galimberti D, Olivecrona G, Klein RS, Cross AH, Otero K, Piccio L, Acta Neuropath, 1/1/2015
• Join now to see all

Books/Book Chapters

• Multiple Sclerosis and CNS Inflammatory Disorders 
  Chapter: Immunopathogenesis of Multiple Sclerosis. 
  Cross AH, Piccio LEditors: LM Samkoff and AD Goodman.Wiley2014
• Multiple Sclerosis and CNS Inflammatory Disorders 
  Chapter: Immunopathogenesis of Multiple Sclerosis. Chapter 2 
  Cross AH, Piccio LEditors: LM Samkoff and AD Goodman.Wiley2014
• Advances in Clinical Chemistry and Laboratory Medicine 
  Chapter: Update on Multiple Sclerosis 
  Cross AHEditors: R Tauber, H Renz.Walter de Gruyter, Berlin2012
• Advances in Clinical Chemistry and Laboratory Medicine 
  Chapter: Update on Multiple Sclerosis 
  Cross AHEditors: R Tauber, H Renz.Walter de Gruyter, Berlin2012
• Primer on Multiple Sclerosis 
  Chapter: Immunology of Multiple Sclerosis 
  Page 47 - 59Piccio L, Cross AHEditors: B. Giesser.Oxford University Press2011
• Primer on Multiple Sclerosis 
  Chapter: Immunology of Multiple Sclerosis. 
  Page 47 - 59Piccio L, Cross AHEditors: B. Giesser.Oxford University Press2011
• Continuum. Multiple Sclerosis 
  Chapter: Magnetic Resonance Imaging of Multiple Sclerosis 
  Naismith RT, Cross AHEditors: AH Cross, RT Naismith.Williams and Wilkins, Hagerstown, Maryland2007
• Continuum. Multiple Sclerosis 
  Chapter: Magnetic Resonance Imaging of Multiple Sclerosis. 
  Naismith RT, Cross AHEditors: AH Cross, RT Naismith.Williams and Wilkins, Hagerstown Maryland2007
• Handbood of Multiple Sclerosis 
  Chapter: MS: An Autoimmune Disease of the CNS? 
  Page 95 - 112Rinker J, Naismith RT, Cross AHEditors: S.D. Cook.Taylor & Francis Group, New YorkEdition 4th,2006
• Handbood of Multiple Sclerosis 
  Chapter: MS: An Autoimmune Disease of the CNS? 
  Page 95 - 112Rinker J, Naismith RT, Cross AHEditors: S.D. Cook.Taylor & Francis Group, New York2006
• Experimental Models of MS 
  Chapter: Endothelial Cells and Adhesion Molecules in Experimental Autoimmune Encephalomyelitis 
  Page 151 - 179Lyons JA, Cross AHEditors: E. Lavi, C. Constantinescu.Springer, New York2005
• Experimental models of MS 
  Chapter: Endothelial cells and adhesion molecules in experimental autoimmune encephalomyelitis. 
  Page 151 - 179Lyons JA, Cross AHEditors: E. Lavi, C. Constantinescu.Springer, New York2005
• The Year in Neurology 
  Chapter: Neuroimmunology 
  Page 99 - 119Naismith RT, Cross AHEditors: E. Faught.Clinical Publishing Services Ltd., Oxford, UK2004
• The Year in Neurology 
  Chapter: Neuroimmunology 
  Naismith RT, Cross AHEditors: E. Faught.Clinical Publishing Services Ltd., Oxford, UK2004
• Handbook of Multiple Sclerosis 
  Chapter: Autoantibodies in Demyelinating Disease 
  Cross AH, Lyons JA, Trotter JLEditors: S. Cook.Marcel Dekker, New YorkEdition 3rd,2000
• Immunology of the Nervous system 
  Chapter: Lymphocyte entry and the initiation of inflammation in the central nervous system. 
  Hickey WF, Lassmann H, Cross AHEditors: R. Keane, W. Hickey.Oxford Press, New York1996
• Handbook of Multiple Sclerosis 
  Chapter: Autoantibodies in Demyelinating Disease. 
  Trotter JL, Cross AHEditors: S. Cook.Marcel Dekker, New YorkEdition 2nd,1996
• Immunology of the Nervous system 
  Chapter: Lymphocyte Entry and the Initiation of Inflammation in the Central Nervous System 
  Hickey WF, Lassmann H, Cross AHEditors: R. Keane, W. Hickey.Oxford Press, New York1996
• Handbook of Multiple Sclerosis 
  Chapter: Autoantibodies in Demyelinating Disease 
  Trotter JL, Cross AHEditors: S. Cook.Marcel Dekker, New YorkEdition 2nd,1996
• Join now to see all

Lectures

• Dr. Murray B. Bornstein Lectureship: The role of B cells in multiple sclerosis 
  Dartmouth-Hitchcock Medical Center and Geisel School of Medicine at Dartmouth, Lebanon NH - 1/2/2018
• B cell targeting agents: mechanisms of action in RRMS and PPMS 
  San Diego, CA - 1/2/2018
• Disease modifying treatment in progressive multiple sclerosis. 
  1/1/2018
• Refining the use of MRI to predict multiple sclerosis. 
  1/1/2018
• Managing Progressive MS 
  San Diego - 1/1/2018
• Imaging Measures of CNS Repair. 
  Consortium of MS Centers, New Orleans - 1/25/2017
• Diffusion imaging to noninvasively discern the neuropathology of MS 
  1/10/2017
• Role of B cells and humoral responses in MS pathophysiology and treatment 
  Seattle, WA - 1/10/2017
• A new imaging modality to non-invasively assess multiple sclerosis pathology. 
  1/1/2017
• B cells in MS 
  University of Alberta, Edmonton Canada - 1/22/2016
• Revival of interest in B-cells in MS pathogenesis 
  Weill Cornell Medical College, New York, NY - 1/13/2016
• B Lymphocyte Depletion in MS � The Coming Revolution 
  University of Alabama, Birmingham - 1/7/2016
• D�j� Vu All Over Again: The Revival of Interest in the Role of B Cells in MS 
  1/29/2015
• Deja Vu All Over Again: The Revival of Interest in the Role of B Cells in MS 
  1/29/2015
• Enhancing our understanding of white matter changes in early multiple sclerosis. 
  1/1/2015
• Update on Multiple Sclerosis 
  Philadelphia, PA - 1/2/2014
• Update on Multiple Sclerosis 
  Philadelphia PA - 1/2/2014
• Active and progressive: A new duality of MS classification. 
  1/1/2014
• MS and related disorders: groundbreaking news. 
  1/1/2014
• Established and novel treatments in multiple sclerosis 
  1/1/2014
• MS Therapeutics: A look into the future 
  Oklahoma City, OK - 1/5/2013
• MS Therapeutics: A Look into the Future 
  Oklahoma City, OK - 1/5/2013
• Assessing humoral immunocompetence after alemtuzumab treatment in MS 
  1/1/2013
• Monoclonal Antibodies as Disease Modifying Therapy in Multiple Sclerosis. 
  1/1/2013
• Adipokines in MS 
  San Diego, CA - 1/1/2012
• Join now to see all

Other

• Estriol Combined with Glatiramer Acetate for Women with Relapsing-remitting Multiple Sclerosis: A Randomized, Placebo-controlled Pahse 2 Trial 
  Voskuhl RR, Wang H, Wu TCJ, Sicotte NL, Nakamura K, Kurth F, Itoh N, Bardens J, Bernard JT, Corboy JR, Cross AH, Chib-Jalbut S, Ford CC, Frohman EM, Giesser B, Jacobs ..., Lancet Neurology
  1/24/2015